Live-birth rate in euthyroid women with recurrent miscarriage and thyroid peroxidase antibodies

Gynecological Endocrinology

Volumn 32, Issue 2, 2016, Pages 132-135

  Vissenberg, Rosa ^a,b   Fliers, Eric ^a   Van Der Post, Joris A M ^a   Van Wely, Madelon ^a   Bisschop, Peter H ^a   Goddijn, Mariette ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Levothyroxine; live birth rate; pregnancy rate; recurrent miscarriage; thyroid autoimmunity; thyroid peroxidase antibodies

Indexed keywords

LEVOTHYROXINE; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; AUTOANTIBODY; AUTOANTIGEN; IODIDE PEROXIDASE; IRON BINDING PROTEIN; THYROXINE; TPO PROTEIN, HUMAN;

ADULT; ARTICLE; AUTOIMMUNITY; BIRTH RATE; COHORT ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; PREGNANCY RATE; PREGNANCY TEST; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; THYROID FUNCTION TEST; BLOOD; IMMUNOLOGY; PREGNANCY; RECURRENT ABORTION;

ABORTION, HABITUAL; ADULT; AUTOANTIBODIES; AUTOANTIGENS; FEMALE; HUMANS; IODIDE PEROXIDASE; IRON-BINDING PROTEINS; LIVE BIRTH; PREGNANCY; RETROSPECTIVE STUDIES; THYROXINE;

EID: 84945231539     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2015.1092513     Document Type: Article

References (12)

1. Rai R, Regan L. Recurrent miscarriage. Lancet 2006; 368: 601-11
2. Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31: 702-55
3. Kaprara A, Krassas GE. Thyroid autoimmunity and miscarriage. Hormones (Athens) 2008; 7: 294-302
4. van den Boogaard E, Vissenberg R, Land JA, et al. Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review. Hum Reprod Update 2011; 17: 605-19
5. Thangaratinam S, Tan A, Knox E, et al. Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence. BMJ 2011; 342: d2616
6. Rushworth FH, Backos M, Rai R, et al. Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies. Hum Reprod 2000; 15: 1637-9
7. Yan J, Sripada S, Saravelos SH, et al. Thyroid peroxidase antibody in women with unexplained recurrent miscarriage: prevalence, prognostic value, and response to empirical thyroxine therapy. Fertil Steril 2012; 98: 378-82
8. Kolte AM, Bernardi LA, Christiansen OB, et al. Terminology for pregnancy loss prior to viability: a consensus statement from the ESHRE early pregnancy special interest group. Hum Reprod 2015; 30: 495-8
9. Goddijn M, van den Boogaard E, Steepers EA, et al. The guideline Recurrent miscarriage' (first revision) of the Dutch Society for Obstetrics and Gynaecology. Ned Tijdschr Geneeskd 2008; 152: 1665-70
10. Jauniaux E, Farquharson RG, Christiansen OB, Exalto N. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod 2006; 21: 2216-22
11. Franssen MT, Korevaar JC, van der Veen F, et al. Management of recurrent miscarriage: evaluating the impact of a guideline. Hum Reprod 2007; 22: 1298-303
12. Vissenberg R, van den Boogaard E, van WM, et al. Treatment of thyroid disorders before conception and in early pregnancy: a systematic review. Hum Reprod Update 2012; 18: 360-73